Business Context and Reporting Period
This Form 8-K, dated January 2, 2026, reports the completion of a major strategic transaction by Occidental Petroleum Corporation (OXY). The filing details the finalization of the divestiture of the company's chemical business segment to Berkshire Hathaway Inc., a transaction originally announced on October 3, 2025.
Key Financial Metrics
- Transaction Value: The divestiture was completed for $9.7 billion in cash, subject to customary purchase price adjustments.
- Pro Forma Data: The filing includes unaudited pro forma condensed consolidated statements of operations for the nine months ended September 30, 2025, and the years ended December 31, 2024, 2023, and 2022, giving effect to the divestiture.
- Balance Sheet Impact: An unaudited pro forma condensed consolidated balance sheet as of September 30, 2025, is provided, reflecting the divestiture and certain debt redemption transactions.
- Specific Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, or total debt levels; these figures are contained within the attached Exhibit 99.2 pro forma financial statements.
Material Changes
The primary material change is the completion of the sale of all issued and outstanding equity interests in Occidental Chemical Corporation to Berkshire Hathaway. This transaction fundamentally alters Occidental's business structure by removing its chemical business segment. The filing notes that the transaction was executed pursuant to a Purchase Agreement dated October 1, 2025.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) issued on January 2, 2026, announcing the completion of the divestiture. No specific forward-looking guidance regarding future production or earnings is detailed in the text of this 8-K.
Risks and Contingencies: The document includes an extensive list of forward-looking statement risks, including:
- Uncertainties and liabilities associated with the divested chemical business, including retained liabilities and indemnification obligations.
- General economic conditions, commodity price volatility, and geopolitical risks (e.g., conflicts in the Middle East and Russia-Ukraine).
- Ability to successfully monetize assets, repay or refinance debt, and manage interest rate changes.
- Operational risks, including HSE liabilities, regulatory changes, and potential impairments of oil and gas properties.
Investor Verification Checklist
- Review Exhibit 99.2 for the specific unaudited pro forma financial statements to understand the post-divestiture revenue, debt, and liquidity position.
- Verify the final purchase price adjustments to the $9.7 billion base transaction value.
- Examine the retained liabilities and indemnification obligations related to the chemical business divestiture.
- Assess the impact of the transaction on Occidental's debt redemption activities mentioned in the pro forma balance sheet.
- Consult the referenced Form 10-K (2024) and Form 10-Q (Q3 2025) for detailed risk factors and historical financial context.